Evidence map›Paper›PMID 40599676›Full record

ArticleUrology case reports2025

Trimodality therapy with salvage focal brachytherapy for seminal vesicle recurrence after prostate cancer brachytherapy.

Makoto Nakiri, Hirofumi Kurose, Shinnosuke Komine, Hiroki Suekane, Katsuaki Chikui, Kosuke Ueda, Keiichiro Uemura, Kiyoaki Nishihara, Koichiro Muraki, Chikayuki Hattori and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Makoto NakiriDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Hirofumi KuroseDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Shinnosuke KomineDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Hiroki SuekaneDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Katsuaki ChikuiDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Kosuke UedaDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Keiichiro UemuraDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Kiyoaki NishiharaDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.
Koichiro MurakiDepartment of Radiology, Kurume University School of Medicine, Kurume, Japan.
Chikayuki HattoriDepartment of Radiology, Kurume University School of Medicine, Kurume, Japan.
Etsuyo OgoDepartment of Radiology, Kurume University School of Medicine, Kurume, Japan.
Tsukasa IgawaDepartment of Urology, Kurume University School of Medicine, Kurume, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvage therapy is effective for treating local recurrence following radiation therapy for prostate cancer. Although surgery, radiation therapy, and hormonal therapy can be considered as options for salvage therapy for seminal vesicle recurrence of prostate cancer, there are reports of poor outcomes, and many cases involve treatment difficulties and post-treatment recurrence. In this article, we report our findings on the use of trimodality therapy, consisting of salvage focal brachytherapy, intensity-modulated radiation therapy, and hormonal therapy, in a patient who showed seminal vesicle recurrence 10 years after brachytherapy, with no major adverse events and no biochemical recurrence over 5 years.

Indexed as

BrachytherapyProstate cancerSalvage focal brachytherapySalvage therapySeminal vesicle recurrence

Identifiers

PMID40599676
PMCPMC12209888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.